Skip Navigation Bar
Thomas C. Chalmers Papers 1927-1995
full text File Size: 233 K bytes | Add this to my bookbag

 
Box | Folder Title
 
Series 3: Hepatitis Study (Kyoto, Japan ), 1943-1970 [series]:

This series contains correspondence, reports, charts, and other data concerning Chalmers' Hepatitis Study in Japan. In 1951 he was the principal investigator of the hepatitis treatment research unit of Harvard Medical School in Kyoto, Japan. This study was later used by Chalmers to disprove the common belief that long periods of bed rest was beneficial to those suffering from acute infectious hepatitis. The series is arranged alphabetically by file folder.

[RESTRICTED PHI POLICY] Series is restricted according to HMD's access to health information policy. Please consult the Manuscripts Curator for access to these materials.

50 1
Acute Hepatitis: Jaundice Study, 1943 [RESTRICTED PHI POLICY]
50 2
Choline Content and Electrolytes and Vitamins: Sample Skeleton Diets: Dietary 2nd Run, 1952-1953 [RESTRICTED PHI POLICY]
50 3
Clinical Data: Onset to Time of Admission [RESTRICTED PHI POLICY]
 
Correspondence [subseries]:
50 4-5
1952-1953 [RESTRICTED PHI POLICY]
50 6
from Chalmers, 1951-1952 [RESTRICTED PHI POLICY]
36 1
from Kyoto, Japan: from Eckhardt, 1952 [RESTRICTED PHI POLICY]
36 2
from Sasebo, Japan, 1952-1953 [RESTRICTED PHI POLICY]
36 3
Kyoto, Japan, 1951-1952 [RESTRICTED PHI POLICY]
36 4
Macleod, 1952-1953 [RESTRICTED PHI POLICY]
36 5
to Chalmers, 1951-1952 [RESTRICTED PHI POLICY]
36 6
to Kyoto, Japan, 1952 [RESTRICTED PHI POLICY]
36 7
to Sasebo, Japan, 1952-1953 [RESTRICTED PHI POLICY]
36 8
Watson, 1952-1953 [RESTRICTED PHI POLICY]
 
Data Nara [subseries]:
36 9
Final Charts and Tables [RESTRICTED PHI POLICY]
36 10
Master Sheets and First Labels Thereof [RESTRICTED PHI POLICY]
 
Data Retrospective [subseries]:
36 11
Math, charts, undated [RESTRICTED PHI POLICY]
36 12
Difference in Effect by TSB [RESTRICTED PHI POLICY]
36 13
Effects of Punch Card Items in Course [RESTRICTED PHI POLICY]
36 14
Rising TSB [RESTRICTED PHI POLICY]
36 15
Data V Clinical Bed Rest: Effects of Ambulation [RESTRICTED PHI POLICY]
36 16
Data VIII Major: 4 Relapses, Etc. [RESTRICTED PHI POLICY]
 
Dietary Data [subseries]:
36 17
Merme [RESTRICTED PHI POLICY]
36 18
Retrospective Analyses: Old Stuff: First Run X, 1952 [RESTRICTED PHI POLICY]
36 19
Discharge Dates, 1st and 2nd Run, 1952 [RESTRICTED PHI POLICY]
37 1
"The Treatment of Acute Hepatitis", J. of Clinical Inverstigation, Draft I, 1955 [RESTRICTED PHI POLICY]
37 2
Epidemic Hemorrhagic Fever, 1951 [RESTRICTED PHI POLICY]
37 3
First Experiment, 1950 [RESTRICTED PHI POLICY]
37 4
Follow-up Chart, 1952-1953 [RESTRICTED PHI POLICY]
37 5
Hepatitis Survey Group, 1952 [RESTRICTED PHI POLICY]
37 6
Infectious Hepatitis Lecture, 1952 [RESTRICTED PHI POLICY]
37 7
Kyoto lectures, 1951-1952 [RESTRICTED PHI POLICY]
37 8
Kyoto Talks, 1951 [RESTRICTED PHI POLICY]
37 9
Liver biopsy blinical reports, 1952 [RESTRICTED PHI POLICY]
37 10
Nara Randomization [RESTRICTED PHI POLICY]
37 11
Physical fitness tests [RESTRICTED PHI POLICY]
37 12-13
Preliminary Data I: Hepatitis Study: Kyoto, Japan, n.d [RESTRICTED PHI POLICY]
37 14
Preliminary Data II: Hepatitis Study: Kyoto, Japan, 1951 [RESTRICTED PHI POLICY]
37 15
Protocols, 1952 [subseries]:  [RESTRICTED PHI POLICY]
38 1
First Run, 1951-1952 [RESTRICTED PHI POLICY]
38 2
Follow-up States, 1952-1953 [RESTRICTED PHI POLICY]
38 3
Second Run, 1952 [RESTRICTED PHI POLICY]
38 4
Code Sheets [RESTRICTED PHI POLICY]
38 5
First Run Data [RESTRICTED PHI POLICY]
 
Randomization [subseries]:  [RESTRICTED PHI POLICY]
38 6
Both Runs III [RESTRICTED PHI POLICY]
38 7
Data 2nd Run [RESTRICTED PHI POLICY]
38 8
Final Data V [RESTRICTED PHI POLICY]
38 9
First Run I [RESTRICTED PHI POLICY]
38 10
Retrospective Data: Preliminary Labeling [RESTRICTED PHI POLICY]
38 11
Study One and Two [RESTRICTED PHI POLICY]
38 12
Supreme Sheet 1st and 2nd Run Data [RESTRICTED PHI POLICY]
38 13-14
The Second Experiment [RESTRICTED PHI POLICY]
38 15
Veterans Follow-Up, 1951 [RESTRICTED PHI POLICY]
38 15-17
Volunteer Study, 1953 [RESTRICTED PHI POLICY]
 
Clinical Trial records [subseries]:
39 1
Best Rest Analysis Both Runs: Adhesive Figures [RESTRICTED PHI POLICY]
39 2
Case Summaries: On Patients Who Have Been Seen, 1952 [RESTRICTED PHI POLICY]
39 3
[Computer Cards], 1952 [RESTRICTED PHI POLICY]
39 4
Data: Weights [RESTRICTED PHI POLICY]
39 5
Dietary Data: Summary Master Flow Sheets: First Run [RESTRICTED PHI POLICY]
 
Follow-up [subseries]:
39 6
Form Letters, 1948-1953 [RESTRICTED PHI POLICY]
39 7
NRC and Other Material, 1949-1952 [RESTRICTED PHI POLICY]
39 8
Patients Addresses, 1952-1953 [RESTRICTED PHI POLICY]
39 9
Study Lists, 1952 [RESTRICTED PHI POLICY]
40 1-3
Hepatology [RESTRICTED PHI POLICY]
40 4
Liver Biopsies III: Personal [RESTRICTED PHI POLICY]
41 1
Second Study Data Graphs [transparencies] [RESTRICTED PHI POLICY]
41 2
Master Summary Diet Sheets: Second Run [RESTRICTED PHI POLICY]
41 3
Names, 1952 [RESTRICTED PHI POLICY]
42 1-106
[Patient participation files], 1952-1953 [RESTRICTED PHI POLICY]
43 1-2
[Patient information cards], 1952 [RESTRICTED PHI POLICY]
43 3
[Patient notecards: Biopsi and Diagnosis Data], 1952 [RESTRICTED PHI POLICY]
43 4
Protocols: Follow-up Sasebo, 1952-1953 [RESTRICTED PHI POLICY]
43 5
Pts. Hospital in Interval, 1952-1953 [RESTRICTED PHI POLICY]
43 6-11
Punch Cards: Patient Treatment Records, 1951-1952 [RESTRICTED PHI POLICY]
44 1-4
Punch Cards: Patient Treatment Records (cont'd.), 1951-1952 [RESTRICTED PHI POLICY]
44 5
Rocket Analysis Cards [patient treatment records] [RESTRICTED PHI POLICY]
44 6
Punched Card Code Sheets [RESTRICTED PHI POLICY]
44 7
Questionnaire Responses and Tabulations, 1952-1953 [RESTRICTED PHI POLICY]
44 8
Sasebo Follow-up: Original Lab Worksheets, 1952-1953 [RESTRICTED PHI POLICY]
44 9
Study Controls [exam results], 1947-1948 [RESTRICTED PHI POLICY]
 
[Patient observation charts], [c. 1952] [subseries]:
45 1
1st Study, Ward #41 [RESTRICTED PHI POLICY]
45 2
1st Study, Ward #23 [RESTRICTED PHI POLICY]
45 3
1st Study, Ward #43 [RESTRICTED PHI POLICY]
45 4
1st Study, Ward #21 [RESTRICTED PHI POLICY]
46 1
2nd Study, Ward #23 [RESTRICTED PHI POLICY]
46 2
2nd Study, Ward #41 [RESTRICTED PHI POLICY]
46 3
2nd Study, Ward #43 [RESTRICTED PHI POLICY]
46 4
2nd Study, Ward #21 [RESTRICTED PHI POLICY]
46 5
Eosimophil Counts [RESTRICTED PHI POLICY]
46 6
Weight Flow Sheets [RESTRICTED PHI POLICY]
46 7
Miscellaneous First Run Laboratory [RESTRICTED PHI POLICY]
46 8
[Unidentified scraps/sheet portions] [RESTRICTED PHI POLICY]
46 9
[Unidentified diagnostic data, ward 21, 23, 41, 43] [RESTRICTED PHI POLICY]